Archive

AMD Disease Education Resource Center: A Provocative AMD Case

Supported by advertising from Regeneron Pharmaceuticals and Carl Zeiss Meditec

View Insert

Noninfectious Posterior Uveitis: The Rationale for Steroid Use

Supported through an unrestricted educational grant by Santen.

View Insert

DME Resource Center: Beyond the Clinical Trials: Sustained-Release Steroid Can Aid Treatment of Refractory DME and Challenging Cases

Supported by advertising from Allergan and Carl Zeiss Meditec

View Insert

Changing Your Perspective in the OR

Supported via advertising by Alcon and Oculus Surgical

View Supplement

Intravitreal Corticosteroids: Ensuring Effective Use With IOP Control

Supported through an unrestricted educational grant by Allergan.

View Supplement

Effective Treatment Strategies for the Management of Diabetic Macular Edema

Supported through an unrestricted educational grant by Alimera Sciences.

View Insert

DME Resource Center: Beyond the Clinical Trials: Adventures in Treating Refractory DME

Supported by advertising from Allergan and Carl Zeiss Meditec

View Insert

Differentiating Primary Intraocular Lymphoma From Uveitis

Supported by advertising from Allergan

View Insert

AMD Disease Education Resource Center: The Effect of Drug Selection on Outcomes in Patients With AMD

Supported by advertising from Regeneron Pharmaceuticals and Carl Zeiss Meditec

View Insert

DME in 2016: A Review of Treatment Guidelines and the Role of Early Appropriate Therapy

Supported by an unrestricted educational grant from Regeneron Pharmaceuticals.

View Supplement

Tips and Pearls for Adopting Small-Gauge Surgery

Supported via advertising from Alcon and Oculus Surgical

View Supplement

Three Pillars of Success in Patient and Practice Management Strategies in Diabetic Macular Edema

Supported via advertising by Alimera Sciences and Optos

View Insert

AMD Disease Education Resource Center: Efficacy and Tolerability of Intravitreal Aflibercept in Patients With Exudative AMD Previously Treated With Ranibizumab or Bevacizumab

Supported by advertising from Regeneron Pharmaceuticals and Carl Zeiss Meditec

View Insert

An Update on the Latest Clinical Trials in Diabetic Macular Edema

Supported via advertising by Regeneron and Notal Vision

View Insert

Opportunities in the Uveitis Treatment Pipeline

Supported by advertising from Allergan

View Insert

Why Consider the Yellow 577 nm Wavelength?

Sponsored by Quantel Medical

View Insert

Looking Into the Future ... Today

Supported via advertising by Alcon and Oculus

View Supplement

AMD in 2016: A Review of Treatment Guidelines and the Role of Early Appropriate Therapy

Supported by an educational grant from Regeneron Pharmaceuticals.

View Supplement

Clinical Case Compendium

Supported via advertising by Alcon and Optos

View Supplement

Three Pillars of Success in Patient and Practice Management Strategies in Diabetic Macular Edema

Supported via advertising by Alimera Sciences and Optos

View Insert

Basic Management of Anterior Scleritis

Supported by advertising from Allergan

View Insert

Dry to Wet Age-Related Macular Degeneration: The Importance of Early Detection

Sponsored by Notal Vision

View Insert

DME Resource Center: Beyond the Clinical Trials: Sometimes DME Control Requires Steroid Treatment

Supported by advertising from Allergan and Carl Zeiss Meditec

View Insert

Management and Treatment of Diabetic Macular Edema After Protocol T

Supported through an unrestricted educational grant by Regeneron Pharmaceuticals.

View Supplement

AMD Disease Education Resource Center: PRN Therapy for Treatment of CNV

Supported by advertising from Regeneron Pharmaceuticals and Carl Zeiss Meditec

View Insert

Current Role for Laser to Treat DME

Sponsored by Quantel Medical

View Insert

Reducing Inflammation and Halting Disease Progression

Sponsored by advertising from Allergan

View Insert

DRCR.net Protocol Review

Supported by an educational grant from Regeneron Pharmaceuticals.

View Insert

Steroid Delivery in Patients With Diabetic Macular Edema in the Presence of a Cataract

Supported by an unrestricted educational grant from Allergan.

View Supplement

The Long-Term Management of Uveitis

Sponsored by Bausch + Lomb

View Supplement

DME Resource Center: Beyond the Clinical Trials: Switching Modes of Therapy to Effectively Treat DME

Supported by advertising from Allergan and Carl Zeiss Meditec

View Insert

Applying Research to Practice for Patients with Diabetes

Supported by an independent educational grant from Regeneron Pharmaceuticals.

View Insert

Viral Anterior Uveitis in The Real World

Sponsored by advertising from Allergan

View Insert

New Paradigms in the Management and Treatment of Diabetic Macular Edema

Supported by an educational grant from Alimera Sciences.

View Supplement